Actavia Life Sciences, Inc. RASP
0.00 USD 0.00 (+0.00%)
At close·Nov 2, 2026, 4:00 PM EST
0.0004 52-week range 0.004
- YTD
- 0.00%
- 1 year
- -87.50%
Altman Z-Score
-909.57 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -2.6×
P/S 0.0×
P/B -5.9×
P/FCF -1357×
EV/EBITDA -2.9×
EV/Sales 0.0×
FCF Yield -0.1%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE 227.2%
ROIC 242.9%
ROA -4644.7%
Revenue 0.0%
Operating Income -3103.8%
EPS (diluted) -24.2%
Free Cash Flow 97.3%
Current Ratio 0.0×
Quick Ratio 0.1×
Debt / Equity -0.1×
Net Debt / EBITDA -0.0×
Interest Coverage -19.9×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2023-09-30